JP7187471B2 - 擬似三糖アミノグリコシドおよびその中間体の大規模調製 - Google Patents

擬似三糖アミノグリコシドおよびその中間体の大規模調製 Download PDF

Info

Publication number
JP7187471B2
JP7187471B2 JP2019551278A JP2019551278A JP7187471B2 JP 7187471 B2 JP7187471 B2 JP 7187471B2 JP 2019551278 A JP2019551278 A JP 2019551278A JP 2019551278 A JP2019551278 A JP 2019551278A JP 7187471 B2 JP7187471 B2 JP 7187471B2
Authority
JP
Japan
Prior art keywords
formula
compound
group
protected
acceptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019551278A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020514373A (ja
JP2020514373A5 (enExample
Inventor
ミズヒリツスキー、ミカエル
コタラ、マニ・ブシャン
パラディ、ラビンデル
Original Assignee
エロックス ファーマシューティカルズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エロックス ファーマシューティカルズ リミテッド filed Critical エロックス ファーマシューティカルズ リミテッド
Publication of JP2020514373A publication Critical patent/JP2020514373A/ja
Publication of JP2020514373A5 publication Critical patent/JP2020514373A5/ja
Application granted granted Critical
Publication of JP7187471B2 publication Critical patent/JP7187471B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/224—Cyclohexane rings substituted by at least two nitrogen atoms with only one saccharide radical directly attached to the cyclohexyl radical, e.g. destomycin, fortimicin, neamine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/228—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings
    • C07H15/23—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to adjacent ring-carbon atoms of the cyclohexane rings with only two saccharide radicals in the molecule, e.g. ambutyrosin, butyrosin, xylostatin, ribostamycin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2019551278A 2017-03-15 2018-03-15 擬似三糖アミノグリコシドおよびその中間体の大規模調製 Active JP7187471B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN201721008996 2017-03-15
IN201721008996 2017-03-15
PCT/IL2018/050306 WO2018167794A1 (en) 2017-03-15 2018-03-15 Large scale preparation of pseudo-trisaccharide aminoglycosides and of intermediates thereof

Publications (3)

Publication Number Publication Date
JP2020514373A JP2020514373A (ja) 2020-05-21
JP2020514373A5 JP2020514373A5 (enExample) 2021-04-30
JP7187471B2 true JP7187471B2 (ja) 2022-12-12

Family

ID=63521924

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019551278A Active JP7187471B2 (ja) 2017-03-15 2018-03-15 擬似三糖アミノグリコシドおよびその中間体の大規模調製

Country Status (9)

Country Link
US (2) US11136345B2 (enExample)
EP (1) EP3609902A4 (enExample)
JP (1) JP7187471B2 (enExample)
CN (2) CN117466958A (enExample)
AU (2) AU2018235441C1 (enExample)
BR (1) BR112019018834A2 (enExample)
CA (1) CA3055883A1 (enExample)
IL (1) IL269364B (enExample)
WO (1) WO2018167794A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021061873A1 (en) * 2019-09-23 2021-04-01 Eloxx Pharmaceuticals, Inc. Methods, compositions, and kits for treating polycystic kidney disease

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013542981A (ja) 2010-11-18 2013-11-28 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド アミノグリコシドおよび遺伝性障害の処置におけるその使用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3897412A (en) 1972-05-04 1975-07-29 Bristol Myers Co Paromomycin antibiotic derivatives
FR2232326B1 (enExample) 1973-06-05 1977-11-10 Pfizer
US4029882A (en) 1974-03-19 1977-06-14 Schering Corporation Selective acylation of the C-1 amino group of aminoglycoside antibiotics
US3996205A (en) 1975-09-08 1976-12-07 The Upjohn Company Aminoglycoside antibiotics and intermediates
JPS543043A (en) 1977-06-10 1979-01-11 Meiji Seika Kaisha Ltd Amino-glycoside antibiotics; 1-n-(omega-aminoalkanesulfonyl)derivatives and their preparation
FR2427341A1 (fr) 1978-06-02 1979-12-28 Delalande Sa Nouveaux derives aminoglycosidiques hemisynthetiques, leur procede de preparation et leur application en therapeutique
JPH0446189A (ja) 1990-06-08 1992-02-17 Meiji Seika Kaisha Ltd 新規なリボスタマイシン誘導体
SI2390255T1 (sl) 2006-04-03 2016-12-30 Technion Research & Development Foundation Ltd. Novi aminoglikozidi in njihove uporabe pri zdravljenju genetskih motenj
WO2011044538A1 (en) * 2009-10-09 2011-04-14 Achaogen, Inc. Antibacterial aminoglycoside analogs
JP2017516835A (ja) * 2014-06-05 2017-06-22 エロックス ファーマシューティカルズ リミテッド レット症候群治療におけるアミノグリコシド類縁体の使用
EP3344641A4 (en) 2015-09-02 2019-09-18 Eloxx Pharmaceuticals Ltd. AMINO-LIKES DERIVATIVES AND USES THEREOF FOR THE TREATMENT OF GENETIC DISEASES
US11306115B2 (en) * 2015-09-02 2022-04-19 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders
US10786520B2 (en) * 2015-09-02 2020-09-29 Eloxx Pharmaceuticals Ltd. Aminoglycoside derivatives and uses thereof in treating genetic disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013542981A (ja) 2010-11-18 2013-11-28 テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド アミノグリコシドおよび遺伝性障害の処置におけるその使用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BRIMACOMBE,J.S. et al，The deamination of methyl 5-amino-5,6-dideoxy-2,3-O-isopropylidene-α-L- talo- and -β-D-allo-furanosides with nitrous acid，Carbohydrate Research，1972年，Vol.25, No.1，p.267-269
DONDONI,A. et al，Stereoselective Addition of 2-Furyllithium and 2-Thiazolyllithium to Sugar Nitrones. Synthesis of Carbon-Linked Glycoglycines，Journal of Organic Chemistry，1997年，Vol.62, No.16，p.5484-5496

Also Published As

Publication number Publication date
CN110637024B (zh) 2023-10-24
CN110637024A (zh) 2019-12-31
US20200079809A1 (en) 2020-03-12
CN117466958A (zh) 2024-01-30
AU2018235441B2 (en) 2022-07-21
JP2020514373A (ja) 2020-05-21
CA3055883A1 (en) 2018-09-20
US20220033428A1 (en) 2022-02-03
AU2018235441A2 (en) 2019-11-07
AU2018235441A1 (en) 2019-09-26
AU2022256098A1 (en) 2022-11-17
IL269364B (en) 2022-04-01
AU2022256098B2 (en) 2024-07-11
AU2018235441C1 (en) 2024-10-24
EP3609902A1 (en) 2020-02-19
AU2022256098C1 (en) 2024-10-31
BR112019018834A2 (pt) 2020-04-14
IL269364A (en) 2019-11-28
EP3609902A4 (en) 2021-01-06
US11136345B2 (en) 2021-10-05
WO2018167794A1 (en) 2018-09-20

Similar Documents

Publication Publication Date Title
JP4790263B2 (ja) 炎症性の疾患および病態を治療する新規な化合物、組成物および方法
JP7335288B2 (ja) アミノグリコシド誘導体および遺伝性疾患の治療におけるその使用
EP3883946A1 (en) Alpha-d-galactoside inhibitors of galectins
US20230097398A1 (en) Aminoglycoside derivatives and uses thereof in treating genetic disorders
US11786539B2 (en) Aminoglycoside derivatives and uses thereof in treating genetic disorders
JP2018528211A5 (enExample)
JPH11514980A (ja) 官能的および空間的に多様な分子を製造するための分子骨格としての２−デオキシストレプタミンとその薬剤組成物
JP7187471B2 (ja) 擬似三糖アミノグリコシドおよびその中間体の大規模調製
KR20100017112A (ko) 젬시타빈의 제조 방법
EP3400232A1 (en) Aminoglycoside derivatives and uses thereof in treating genetic disorders
WO1992019638A1 (en) 1-β-D-ARABINOFURANOSYL-(E)-5-(2-HALOGENOVINYL)-URACIL DERIVATIVE
JPWO2016027755A1 (ja) Ｃ−４”位置換マクロライド化合物
KR20010074428A (ko) 뉴클레오시드

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210315

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210315

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220329

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220629

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220929

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20221101

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20221130

R150 Certificate of patent or registration of utility model

Ref document number: 7187471

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250